Innovator IBD 50 ETF Rating $40.66 0.00 (0.00%) As of 07/2/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsBuy This Stock Innovator IBD 50 ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FFTY Aggregate RatingModerate Buy 2.84Holdings in FFTY have an aggregate rating of Moderate Buy based on 383 analyst ratings issued in the past year covering 24 companies (71.6% of the portfolio).FFTY Aggregate Price Target$40.66High Prediction$40.66Average Prediction$40.66Low Prediction$40.66Holdings in FFTY have an aggregate price target of $40.66 and a range of $40.66 to $40.66 covering 24 companies (71.6% of the portfolio).FFTY Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy8 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Innovator IBD 50 ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 24 FFTY Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.72%TVTXTravere Therapeutics$56.900.0%2.0881 of 5 stars2.69$52.08 -8.5%13News CoveragePositive News3.68%LQDALiquidia$78.933.1781 of 5 stars2.82$68.88 -12.7%113.60%CRSCarpenter Technology$597.44+0.0%3.7166 of 5 stars2.80$481.75 -19.4%10Positive NewsAnalyst ForecastAnalyst RevisionGap Up3.57%GHGuardant Health$167.981.8785 of 5 stars2.96$147.32 -12.3%24Analyst ForecastInsider TradeGap Up3.38%ASTHAstrana Health$49.172.4173 of 5 stars2.78$45.00 -8.5%9News Coverage3.31%AMDAdvanced Micro Devices$517.823.3637 of 5 stars2.72$448.78 -13.3%43Trending NewsAnalyst ForecastAnalyst RevisionGap Up3.31%CRDOCredo Technology Group$241.914.2221 of 5 stars3.00$263.11 8.8%19Trending NewsInsider TradeGap Up3.29%AGXArgan$706.30+0.0%3.4979 of 5 stars2.75$470.40 -33.4%8Gap Up3.26%FIXComfort Systems USA$1,741.160.0%4.8018 of 5 stars2.82$1,991.50 14.4%11Positive NewsAnalyst RevisionGap Up3.22%KNSAKiniksa Pharmaceuticals International$64.533.208 of 5 stars3.00$62.71 -2.8%9Positive NewsGap Down3.14%MUMicron Technology$975.564.9314 of 5 stars3.05$1,263.76 29.5%38Trending NewsInsider TradeAnalyst RevisionGap Up3.13%HUTHut 8$97.143.7611 of 5 stars2.89$115.79 19.2%18Gap Up3.13%ALABAstera Labs$406.423.1345 of 5 stars2.52$265.75 -34.6%23Insider TradeGap Up3.09%TGTXTG Therapeutics$53.313.3699 of 5 stars2.75$58.60 9.9%82.90%TSMTaiwan Semiconductor Manufacturing$434.71+0.1%4.8114 of 5 stars3.00$449.38 3.4%16Trending NewsAnalyst RevisionGap Up2.88%CECOCECO Environmental$82.154.8196 of 5 stars3.00$102.83 25.2%92.76%DYDycom Industries$437.24-0.1%4.869 of 5 stars3.15$554.92 26.9%13News CoverageGap Up2.58%LRCXLam Research$351.414.6762 of 5 stars2.82$345.39 -1.7%34Positive NewsAnalyst ForecastAnalyst RevisionGap Up2.54%OUSTOuster$49.841.9586 of 5 stars2.43$48.17 -3.4%7Trending NewsGap Up2.40%OSCROscar Health$32.09-0.3%2.9623 of 5 stars2.17$20.78 -35.2%12Insider Trade2.21%DAVEDave$387.363.4888 of 5 stars3.00$338.40 -12.6%13Analyst Downgrade2.16%SNEXStoneX Group$120.552.499 of 5 stars3.25$122.00 1.2%4Insider TradeGap Up2.15%HNGEHinge Health$84.15+0.1%2.6612 of 5 stars2.95$75.80 -9.9%19Insider Trade2.14%KRYSKrystal Biotech$375.072.5418 of 5 stars2.83$340.56 -9.2%12Positive NewsAnalyst Downgrade This page (NYSEARCA:FFTY) was last updated on 7/5/2026 by MarketBeat.com Staff. From Our PartnersTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredBetter than SpaceX? Grab this ticker instead.Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innovator IBD 50 ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Innovator IBD 50 ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FFTY Stock Alerts